---
document_datetime: 2025-05-05 14:27:38
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/circadin-epar-all-authorised-presentations_en.pdf
document_name: circadin-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0796372
conversion_datetime: 2025-12-18 08:52:45.124272
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented)   | Strength   | Pharmaceutical Form      | Route of Administration   | Immediate Packaging    | Pack size                  |
|------------------|--------------|------------|--------------------------|---------------------------|------------------------|----------------------------|
|                  | name         |            |                          |                           |                        |                            |
| EU/1/07/392/001  | Circadin     | 2 mg       | Prolonged-release tablet | Oral use                  | blister (PVC/PVDC/alu) | 21 tablets                 |
| EU/1/07/392/002  | Circadin     | 2 mg       | Prolonged-release tablet | Oral use                  | blister (PVC/PVDC/alu) | 20 tablets                 |
| EU/1/07/392/003  | Circadin     | 2 mg       | Prolonged-release tablet | Oral use                  | blister (PVC/PVDC/alu) | 30 tablets                 |
| EU/1/07/392/004  | Circadin     | 2 mg       | Prolonged-release tablet | Oral use                  | blister (PVC/PVDC/alu) | 7 tablets                  |
| EU/1/07/392/005  | Circadin     | 2 mg       | Prolonged-release tablet | Oral use                  | blister (PVC/PVDC/alu) | 30 x 1 tablets (unit dose) |